In Depth 30 Apr 2025 The future of NSCLC treatment: what’s in store for the therapeutic space? Here we delve into the different kinds of NSCLC therapies in the running to potentially address late-stage cancer that is often difficult to treat. April 30, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Apr 2025 The past, present, and future of genome sequencing Genome sequencing is the process of determining the complete DNA sequence of an organism’s genome, a step-by-step decoding of all the genetic instructions. In humans, that means reading around 3 billion base pairs to reveal everything from disease risk and drug response to ancestry and evolution. For many years, genome sequencing was largely limited to […] April 25, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 23 Apr 2025 The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in on FDA approval. April 23, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 17 Apr 2025 Biomaterials in construction: meet the startups reinventing our buildings We will explore the various biomaterials making a mark in the construction field and how biotechs could potentially transform a carbon-intensive industry. April 17, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 14 Apr 2025 Metabolomics: The study of biology’s dark matter Learn about metabolomics, biology’s fourth language that has remained vastly untapped up until now and could accelerate biotech research. April 14, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 11 Apr 2025 Basel: What’s behind the success of one of Europe’s leading biotech hubs? Find out what makes Basel’s biotech hub so successful, as it has cemented its place as one of Europe’s brightest life sciences ecosystems. April 11, 2025 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Apr 2025 Cystic fibrosis: is the next blockbuster a gene therapy? Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need. April 9, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Apr 2025 Will tRNA therapy be the next big thing in genetic disease treatment? Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment. April 7, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 2 Apr 2025 Beyond amyloid: The search for the next big thing in Alzheimer’s treatment Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments. April 2, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 1 Apr 2025 The biggest biotech funding rounds in March 2025 The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025. April 1, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Mar 2025 A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations Delve into the kinase inhibitors’ diverse landscape, from cancer breakthroughs to autoimmune disease innovations. March 26, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 19 Mar 2025 Breast cancer treatments heat up: Five therapies poised to transform patient outcomes Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different approaches. March 19, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email